RELIABILITY AND VALIDITY OF DISORDERS AMONG DRUG ABUSERS

药物滥用者疾病的可靠性和有效性

• 批准号: 2116148
• 负责人: WILSON M COMPTON
• 金额: $ 13.16万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-05-01 至 1999-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2116148
• 关键词: allied health personnel; diagnosis design /evaluation; diagnosis quality /standard; disease /disorder proneness /risk; drug abuse; drug detection; drug withdrawal; human subject; interview; medical records; mental disorder diagnosis; mental disorders; sign /symptom; substance abuse related disorder; videotape /videodisc; allied health personnel; diagnosis design /evaluation; diagnosis quality /standard; disease /disorder proneness /risk; drug abuse; drug detection; drug withdrawal; human subject; interview; medical records; mental disorder diagnosis; mental disorders; sign /symptom; substance abuse related disorder; videotape /videodisc

The aims of the project are: i. to assess selected aspects of reliability of DSM and ICD substance use and non-substance use psychiatric diagnoses with a non-clinician-clinician, test-retest design using state-of-the-art structured and semi-structured assessment tools among 100 drug users who are risk for other psychiatric disorders. Trained non-clinicians will use the WHO/ADAMHA Composite International Diagnostic Interview (CIDI) for substance use diagnoses; the clinicians will use the WHO/ADAMHA Schedules for Clinical Assessment in Neuropsychiatry (SCAN) for all diagnoses. ii. to assess certain aspects of validity of the DSM and ICD substance use and non-substance use psychiatric diagnoses derived from the CIDI/SAM and SCAN by comparing the data from these single source interviews to modified LEAD standard diagnoses. Expert clinicians will determine DSM and ICD "expert/all sources" diagnoses based on reviewing several sources of information including: videotaped recording of the CIDI/SAM and SCAN interviews, records of interviews with collateral sources, results from questioning respondent about discrepancies between the two interviews, urine drug screen results and medical record data iii. to evaluate reasons for differences in responses during the two diagnostic interviews through a Discrepancy Interview Protocol. iv. to compare results of this study with those of a current study on the reliability of substance use diagnoses. v. to funnel information from this study to the CIDI and SCAN Editorial Committees at WHO and to the authors of the SAM to help them refine these diagnostic instruments. In early phases of the project, the Applicant will work with authors of the SAM to insure adequate coverage of the latest DSM-IV and ICD-10 substance use disorders criteria, including the specific withdrawal syndromes and substance induced mental disorders.

该项目的目的是：i。评估可靠性的选定方面 DSM和ICD药物使用和非固定使用精神诊断 使用最先进的非临床医生，测试重测 100名吸毒者中的结构化和半结构化评估工具 是其他精神疾病的风险。 训练有素的非临床医生会 使用WHO/ADAMHA复合国际诊断访谈（CIDI） 用于吸毒诊断；临床医生将使用WHO/ADAMHA 全体神经精神病学（扫描）临床评估的时间表 诊断。 ii。评估DSM和ICD有效性的某些方面 源自物质的使用和非固定使用精神病诊断 CIDI/SAM和扫描通过比较这些单一源的数据 访谈以修改铅标准诊断。 专业临床医生会 根据审查确定DSM和ICD“专家/所有来源”诊断 几个信息来源，包括：录像的录音 CIDI/SAM和扫描访谈，抵押品的采访记录 来源，质疑受访者有关差异的结果 两次访谈，尿液药物筛查结果和病历数据 iii。 评估两者中响应差异的原因 通过差异访谈协议进行诊断访谈。 iv。到 将本研究的结果与当前研究的结果进行比较 药物使用诊断的可靠性。 v。从 这项研究向CIDI和扫描编辑委员会 SAM的作者帮助他们完善这些诊断工具。 在 该项目的早期阶段，申请人将与 SAM确保最新的DSM-IV和ICD-10物质的足够覆盖范围 使用疾病标准，包括特定的戒断综合征和 物质引起的精神障碍。